Cancer Today

Cancer Today, a publication released every three months by the American Association for Cancer Research, serves as a trusted source for cancer patients, survivors, and their loved ones. Each issue provides valuable information and encouragement to help navigate the difficulties of diagnosis, treatment, survivorship, and caregiving.

National, Consumer

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#681592

United States

#158088

Health/Health Conditions and Concerns

#377

Traffic sources

Monthly visitors

Articles

May 9: The Week in Cancer News

1 week ago | cancertodaymag.org | Kevin McLaughlin

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. A single dose of a human papillomavirus (HPV) vaccine provides similar protection from the disease as two doses, according to results of the ESCUDDO trial presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.
May 2: The Week in Cancer News

2 weeks ago | cancertodaymag.org | Eric Fitzsimmons

Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter. Surgery is a staple of early-stage cancer care, but select patients whose cancer responds to immunotherapy may not need to undergo an operation, according to a presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago.
Researchers Tackle Immune-related Adverse Effects

2 weeks ago | cancertodaymag.org | Marci Landsmann

APPROXIMATELY 40% of people with cancer who receive immune checkpoint inhibitors will experience immune-related adverse events (irAEs), ranging from mild symptoms of fatigue and rash to life-threatening conditions that can lead to hospitalizations and even death.
Tissue and Liquid Biopsy for Targeted Therapy

2 weeks ago | cancertodaymag.org | Eric Fitzsimmons

PATIENTS EXPERIENCED longer survival and more time without cancer progressing when doctors used both liquid biopsy and traditional biopsy on tumor tissue to select tailored treatment, according to findings from the ROME study. Though treatment based on biomarkers detected in either blood or tumor tissue, but not both, were also associated with higher survival than standard of care in some cases, the largest increase in survival was in patients where the results of both tests agreed.
Cancer Vaccines Show Promise in Early Trials

2 weeks ago | cancertodaymag.org | Thomas Celona

CANCER VACCINATION offers the promise of training the body’s immune system to identify and attack cancer cells from within. While this technology is one of the most exciting topics in cancer research, many investigational vaccines have not been effective in human trials. But in the past decade, researchers have learned more about immunology, identified new targets and developed novel technologies, fueling optimism about this approach, according to Darrell J.
Declining Breast Cancer Mortality in Younger Women

2 weeks ago | cancertodaymag.org | Kevin McLaughlin

BREAST CANCER DEATH RATES declined dramatically between 2010 and 2020 for U.S. women ages 20 to 49, according to a study presented at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. (The AACR publishes Cancer Today.)Using breast cancer data from the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) program, researchers analyzed 11,661 breast cancer deaths in the decade between 2010 and 2020.
Missed Activities Due to Cancer-related Fatigue and Depression

2 weeks ago | cancertodaymag.org | Eric Fitzsimmons

PHYSICAL ACTIVITY has been linked with a number of benefits, both physical and emotional, for cancer patients. But a study presented April 29 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago found that cancer-related fatigue and depression were associated with decreased recreational physical activity and were more likely to affect women.
Immunotherapy Improves Results in Head and Neck Cancer

2 weeks ago | cancertodaymag.org | Thomas Celona

ADDING IMMUNOTHERAPY to standard care can help reduce recurrence risk for people with locally advanced head and neck cancers, according to a presented April 27 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. (The AACR publishes Cancer Today.)People diagnosed with head and neck cancer typically undergo surgery to remove the tumor, followed by radiation and, in some cases, chemotherapy to reduce their risk of the cancer returning.
Federal Support for Cancer Research Takes the Stage at AACR Annual Meeting

2 weeks ago | cancertodaymag.org | Kevin McLaughlin

ON A DAY when thousands of cancer researchers held up placards reading “Cancer Research Saves Lives” at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago, researchers, former directors of federal agencies and cancer survivors discussed the crisis in federal support for research. (The AACR publishes Cancer Today.)Delays and halts in federal funds and staff layoffs at federal agencies put cancer research and future treatment breakthroughs at risk, said Patricia M.
Controlling Cancer Without Surgery

2 weeks ago | cancertodaymag.org | Thomas Celona

SURGERY TO REMOVE a tumor is a common part of cancer care. The procedure can rid the body of the disease, but it comes with a host of potential risks and life-changing side effects. For example, people who have their stomach or esophagus removed face difficulty eating, and people who have surgery for rectal cancer often need a permanent colostomy bag.